Nipro Corporation (TYO:8086)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Medical Related		512.01B	459.33B	426.07B	379.85B	353.77B
Medical Related Growth		11.47%	7.81%	12.17%	7.37%	3.48%
Unallocated Adjustment		-83.78B	-71.40B	-38.26B	-35.18B	-32.41B
Pharmaceutical related		142.96B	129.61B	95.23B	94.98B	87.05B
Pharmaceutical related Growth		10.30%	36.10%	0.27%	9.11%	-2.15%
Others		7.29B	4.96B	4.44B	2.66B	2.35B
Others Growth		46.97%	11.68%	67.38%	13.12%	49.78%
Pharma Packaging		66.10B	64.29B	57.72B	52.49B	44.81B
Pharma Packaging Growth		2.82%	11.38%	9.95%	17.15%	6.98%
Total		644.59B	586.78B	545.20B	494.79B	455.56B
Total Growth		9.85%	7.63%	10.19%	8.61%	2.95%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan		314.47B	304.60B	290.18B	280.09B	270.54B
Japan Growth		3.24%	4.97%	3.60%	3.53%	1.06%
U.S.A		130.15B	108.02B	98.09B	78.24B	71.57B
U.S.A Growth		20.49%	10.12%	25.37%	9.32%	11.56%
Europe		92.63B	77.20B	68.29B	60.38B	52.17B
Europe Growth		19.99%	13.05%	13.11%	15.74%	2.69%
Asia		107.33B	96.96B	88.64B	76.08B	61.28B
Asia Growth		10.70%	9.39%	16.51%	24.15%	2.38%
Total		644.58B	586.78B	545.20B	494.79B	455.56B
Total Growth		9.85%	7.63%	10.19%	8.61%	2.95%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 13, 2026

Data Sources Report a data error